News

All news CSR Events General PERSONAL CARE Press release Products & Technologies Protéus

SEQENS announces the appointement of a new CEO

France-based SEQENS, a leader in the development and production of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, announces that Pascal Villemagne has been named Chief Executive Officer, effective 1st April 2025. Pascal brings a wealth of experience to the role, having previously served as CEO of CARBOGEN AMCIS, a company specializing in the manufacture … Continued

Read more

SK Capital becomes the new majority shareholder of Seqens – Q&A

SEQENS unveils its new pharmaceutical quality control laboratory in the presence of Jean Castex, French Prime Minister.

Eurazeo announces that it has entered into exclusive discussions to sell its stake in SEQENS

Labcom HitCat Inauguration in partnership with the CNRS

France Relance program: SEQENS new paracetamol production unit

Essential molecules’ production in France: our investment plan

Seqens’ commitment to reducing its carbon footprint

New collaboration between SEQENS and RONDOL

Decarbonization: SEQENS becomes a reference for the industry

A new 45,000 tons ISOPROPANOL production facility

Essential molecules: SEQENS invests in new technologies